Galena Biopharma Reports Second Quarter 2016 Financial Results and Provides a Corporate Update
Aug 09, 2016 20:05 pm UTC| Business
Advancing GALE-401 (Anagrelide CR) into a pivotal trial for the treatment of essential thrombocythemiaClosing NeuVax Phase 3 PRESENT trialNeuVax combination trials with trastuzumab continueWebcast and conference call...
Stereotaxis Reports 2016 Second Quarter Financial Results
Aug 09, 2016 20:05 pm UTC| Business
Ventricular tachycardia procedures increased 24% year over year, representing the 10th consecutive quarter of year-over-year volume growthThree Niobe® system installations completed, including the second installation in...
Rightside Announces Second Quarter 2016 Financial Results
Aug 09, 2016 20:05 pm UTC| Business
KIRKLAND, Wash., Aug. 09, 2016 -- Rightside Group, Ltd. (Nasdaq:NAME), a leading provider of domain name services that advance the way businesses and consumers define and present themselves online, today announced...
KEYW Reports Second Quarter 2016 Financial Results
Aug 09, 2016 20:05 pm UTC| Business
Revenue from continuing operations of $73.3 million, up 1.3% after excluding SETA revenue from same period last yearGAAP EPS from continuing operations of ($0.01); normalization of tax provision would add $0.05 to GAAP...
Portola Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update
Aug 09, 2016 20:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2016 -- Portola Pharmaceuticals Inc.® (NASDAQ:PTLA) today provided a corporate update and reported its financial results for the quarter ended June 30, 2016. “We made significant...
Cavco Industries Reports Fiscal 2017 First Quarter Results
Aug 09, 2016 20:05 pm UTC| Business
PHOENIX, Aug. 09, 2016 -- Cavco Industries, Inc. (NASDAQ:CVCO) today announced financial results for the first fiscal quarter ended July2, 2016. Financial highlights include the following: Net revenue for the first...
Codexis Reports Financial Results for the Second Quarter of 2016
Aug 09, 2016 20:05 pm UTC| Business
Net income reaches $2.2 million; revenues of $16.0 million include milestone payments from GSK and a major biopharmaceutical company, and 62% growth in core biocatalyst product sales Conference call begins at 4:30 p.m....